Versaflex™ HC Thermoplastic Elastomers: high-performance medical-grade formulations for demanding applications, including medical tubing, gaskets and stoppers, and bags, bottles and films. The portfolio also boasts the addition of Versaflex™ HC BT218, a new biopharmaceutical tubing grade developed in response to supply challenges and sterilization concerns for an array of medical devices

The manufacturer worked with Avient to formulate a custom Versaflex™ TPE that featured a low durometer with excellent resistance to adhesion (sticking). But before making the decision to switch from silicone to the Versaflex material, the company needed to feel confident that it would recoup its capital, which included a $50,000 investment in new tooling, within 12 months.

Versaflex Most GLS styrenic TPEs (Dynaflex and some Versaflex) have fairly high mold shrinkage and cause the overmolding TPE to contract more than the substrate, which can result in warpage or cupping of the substrate part.

The resulting custom-formulated grades of GLS™ Dynalloy™ OBC and Versaflex™ TPE allowed the manufacturer to switch to a two-shot molding process that eliminated the time-consuming and costly assembly operations needed for the old part. Reduced assembly costs: Switching to Dynalloy™ OBC and Versaflex™ TPE allowed the introduction of two-shot molding, which eliminated a multi-component assembly process.

More E-Battery Systems for Electric Vehicles As battery enclosures evolve into integrated structural components, the need for advanced materials has grown.

Avient corporation first quarter 2023 results AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) F E B R U A R Y 2 0 2 4 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Continue fostering our Great Place to Work® culture Strategic Objectives Long Term Growth Rates Growth Drivers $340 $455 $790 $1,135 2016 2018 2020 2023 $51 $84 $212 $645 2016 2018 2020 2023 $108 $113 $231 $230 2016 2018 2020 2023 $265 $358 $726 $725 2016 2018 2020 2023 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable Growth Great Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 Adjusted EPS TOP -T IE R S US TAINABIL IT Y P E RF ORM ANCE AND RE COGNIT ION Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile 5 Avient CDP Score: A- F E B R U A R Y 1 4 , 2 0 2 4 W E B C A S T P R E S E N T AT I O N DR. AS HIS H KHANDP UR P R E S I D E N T & C E O 7 8 PORTFOLIO TRANSFORMATION 8 7% 46% 66% 87% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2020 2023 % o f A dj us te d E B IT D A Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications SUSTAINABILITY AS A GROWTH DRIVER 9 LONG-TERM REVENUE GROWTH DRIVERS Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other 60%+ Key Growth Drivers Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other 0–2% Avient 6% END MARKET OBSERVATIONS ( % O F C O M PA N Y S A L E S ) ENERGY 5% DEFENSE 7% TELECOMMUNICATIONS 4% HEALTHCARE 7% 10 TRANSPORTATION 10% INDUSTRIAL 16% BUILDING & CONSTRUCTION 9% CONSUMER 19% PACKAGING 23% 11 REGIONAL OBSERVATIONS ( % O F C O M PA N Y S A L E S ) 11 US & Canada Latin America EMEA Asia 41% 36% 18% 5% Q 4 2 0 2 3 R E S U L T S Q4 2023 PERFORMANCE VS.

Avient corporation first quarter 2023 results AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) F E B R U A R Y 2 0 2 4 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Continue fostering our Great Place to Work® culture Strategic Objectives Long Term Growth Rates Growth Drivers $340 $455 $790 $1,135 2016 2018 2020 2023 $51 $84 $212 $645 2016 2018 2020 2023 $108 $113 $231 $230 2016 2018 2020 2023 $265 $358 $726 $725 2016 2018 2020 2023 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable Growth Great Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 Adjusted EPS TOP -T IE R S US TAINABIL IT Y P E RF ORM ANCE AND RE COGNIT ION Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile 5 Avient CDP Score: A- F E B R U A R Y 1 4 , 2 0 2 4 W E B C A S T P R E S E N T AT I O N DR. AS HIS H KHANDP UR P R E S I D E N T & C E O 7 8 PORTFOLIO TRANSFORMATION 8 7% 46% 66% 87% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2020 2023 % o f A dj us te d E B IT D A Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications SUSTAINABILITY AS A GROWTH DRIVER 9 LONG-TERM REVENUE GROWTH DRIVERS Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other 60%+ Key Growth Drivers Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other 0–2% Avient 6% END MARKET OBSERVATIONS ( % O F C O M PA N Y S A L E S ) ENERGY 5% DEFENSE 7% TELECOMMUNICATIONS 4% HEALTHCARE 7% 10 TRANSPORTATION 10% INDUSTRIAL 16% BUILDING & CONSTRUCTION 9% CONSUMER 19% PACKAGING 23% 11 REGIONAL OBSERVATIONS ( % O F C O M PA N Y S A L E S ) 11 US & Canada Latin America EMEA Asia 41% 36% 18% 5% Q 4 2 0 2 3 R E S U L T S Q4 2023 PERFORMANCE VS.

Versaflex™ GP 2810-40 AM Versaflex™ CE 3120-65 AM Thermoplastic Elastomers: GLS™ Versaflex™

Versaflex ™OM Thermoplastic Elastomer provided a formulation with better wear resistance and met anti-static standard surface resistivity Gravi-Tech™ Density Modified Formulations and Versaflex™ TPEs for Cosmetics Packaging (Chinese) Enhance your cosmetic packaging with Gravi-Tech and Versaflex solutions (Chinese language version)

Gravi-Tech™ Density Modified Formulations and Versaflex™ TPEs for Cosmetics Packaging Enhance your cosmetic packaging with Gravi-Tech and Versaflex solutions Nymax™ nylon substrate and Versaflex™ TPE overmold combine to deliver structural integrity and comfort for archery OEM